Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.15 EUR | -0.32% | -5.53% | -7.38% |
May. 22 | Nanobiotix: strategy update, share price declines | CF |
May. 21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.38% | 315M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+40.01% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment